Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

23 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
CD8+ CD226high T cells in liver metastases dictate the prognosis of colorectal cancer patients treated with chemotherapy and radical surgery.
Viot J, Abdeljaoued S, Vienot A, Seffar E, Spehner L, Bouard A, Asgarov K, Pallandre JR, Renaude E, Klajer E, Molimard C, Monnien F, Bibeau F, Turco C, Heyd B, Peixoto P, Hervouet E, Loyon R, Doussot A, Borg C, Kroemer M. Viot J, et al. Among authors: loyon r. Cell Mol Immunol. 2023 Apr;20(4):365-378. doi: 10.1038/s41423-023-00978-2. Epub 2023 Jan 30. Cell Mol Immunol. 2023. PMID: 36717657 Free PMC article.
SALL4-related gene signature defines a specific stromal subset of pancreatic ductal adenocarcinoma with poor prognostic features.
Vienot A, Monnien F, Truntzer C, Mougey V, Bouard A, Pallandre JR, Molimard C, Loyon R, Asgarov K, Averous G, Ghiringhelli F, Bibeau F, Peixoto P, Borg C. Vienot A, et al. Among authors: loyon r. Mol Oncol. 2023 Jul;17(7):1356-1378. doi: 10.1002/1878-0261.13370. Epub 2023 Jan 21. Mol Oncol. 2023. PMID: 36587397 Free PMC article.
Chemokine switch regulated by TGF-β1 in cancer-associated fibroblast subsets determines the efficacy of chemo-immunotherapy.
Vienot A, Pallandre JR, Renaude E, Viot J, Bouard A, Spehner L, Kroemer M, Abdeljaoued S, van der Woning B, de Haard H, Loyon R, Hervouet E, Peixoto P, Borg C. Vienot A, et al. Among authors: loyon r. Oncoimmunology. 2022 Nov 12;11(1):2144669. doi: 10.1080/2162402X.2022.2144669. eCollection 2022. Oncoimmunology. 2022. PMID: 36387055 Free PMC article.
Harnessing Antitumor CD4+ T Cells for Cancer Immunotherapy.
Ben Khelil M, Godet Y, Abdeljaoued S, Borg C, Adotévi O, Loyon R. Ben Khelil M, et al. Among authors: loyon r. Cancers (Basel). 2022 Jan 5;14(1):260. doi: 10.3390/cancers14010260. Cancers (Basel). 2022. PMID: 35008422 Free PMC article. Review.
23 results